U.S. Science in Crisis: Funding Cuts & Impact of Trump’s Return | STAT News

The landscape of U.S. Science is facing a period of significant disruption, even as some legal challenges to recent policy shifts are resolved. New data reveals a concerning trend: a substantial number of Covid-19 deaths may have gone uncounted during the early stages of the pandemic, particularly among minority groups. Simultaneously, a STAT survey paints a stark picture of the anxieties felt by federally funded researchers following the return of President Trump, leading to scaled-back ambitions and, in some cases, lab closures.

The Shadow of Uncounted Loss

A recent study suggests the official U.S. Covid-19 death toll, currently around 840,000 for 2020 and 2021, may be significantly underestimated. Researchers, utilizing artificial intelligence to analyze data, estimate as many as 155,000 additional deaths likely occurred outside of hospital settings during that period – representing roughly 16% of the reported total. The study highlights that these unrecognized deaths disproportionately affected Hispanic individuals and other people of color in the Southern and Southwestern United States. This finding underscores the importance of comprehensive data collection and analysis to accurately assess the pandemic’s true impact and inform future public health strategies.

The World Health Organization has too updated its recommendations regarding Covid-19 vaccination. High-risk groups, such as older adults, are now advised to receive two shots annually, six months apart. For other adults and children, annual routine vaccination is recommended. However, the WHO advises against routine vaccination for healthy children aged 6 months to 23 months unless a country experiences a significant surge in illness within this age group.

A Climate of Uncertainty for U.S. Researchers

The return of President Trump has cast a shadow over the U.S. Scientific community. A STAT survey of nearly 1,000 federally funded researchers reveals widespread concern and a scaling back of research ambitions. More than a quarter of respondents have been forced to lay off lab members and over 40% have cancelled planned research projects. A striking two-thirds have advised students to consider career paths outside of academia. Despite some courts reversing grant terminations and Congress thwarting plans to slash the National Institutes of Health (NIH) budget, only 35% of respondents whose funding was cut or delayed reported full restoration by the end of 2025. One researcher described the situation as “like the Titanic hitting the iceberg.”

The impact is broad. The survey findings, detailed in STAT’s main story, are bolstered by interviews with 30 researchers detailing their experiences. A companion piece, illuminating the struggles of three researchers, provides a more personal look at the challenges facing the next generation of scientists. This situation raises concerns about the long-term health of U.S. Innovation and its ability to address critical challenges in medicine and public health.

The Complexities of Vaccine Skepticism

Beyond the immediate concerns of funding and research disruption, broader questions about public health are also emerging. Amidst ongoing backlash following the Covid-19 pandemic and fueled by figures like Health Secretary Robert F. Kennedy Jr., vaccine skepticism is gaining traction. Critics emphasize individual autonomy and “medical freedom” in vaccination decisions. However, STAT’s Helen Branswell argues that this focus on individual choice overlooks the crucial indirect benefits that widespread vaccination provides to entire communities. Her analysis highlights how vaccines can protect not only those who receive them but also vulnerable populations who may not be able to be vaccinated or who have a reduced immune response.

For example, the introduction of a vaccine against pneumococcal disease led to a decline in rates of the disease across all age groups, including older adults. Vaccination against chickenpox reduces the risk of shingles later in life, and HPV vaccination protects both vaccinated girls and boys from certain cancers. These examples demonstrate the interconnectedness of public health and the importance of considering the collective benefits of vaccination programs.

Navigating a Shifting Landscape of Healthcare Access

The Trump administration’s efforts to combat healthcare fraud are raising concerns about potential unintended consequences for individuals with disabilities. Even as aiming to protect taxpayer dollars, these efforts may lead to cuts in critical services for a vulnerable population. Federal officials have threatened to withhold funding from Medicaid services in states like Minnesota and have placed a moratorium on new durable medical equipment suppliers. Similar investigations are underway in Florida.

Advocates fear that broadly targeting state Medicaid funding will jeopardize the health and well-being of individuals with disabilities, particularly given that more than a quarter of Americans have a disability and Medicaid funding was already significantly reduced by a previous tax bill. The Baltimore Sun reports on the growing anxieties within the medical community regarding these potential cuts. The situation underscores the need for a balanced approach that addresses healthcare fraud without compromising access to essential services for those who rely on them.

Premature Menopause and Heart Disease Risk

New research published in JAMA Cardiology suggests a link between premature menopause (defined as the end of menstrual periods before age 40) and an increased risk of coronary heart disease. While the underlying mechanisms are still unclear, the study’s findings are particularly concerning for Black women, who are three times more likely than white women to experience premature menopause. The study tracked over 10,000 women over several decades, revealing a significantly higher incidence of heart disease among those who entered menopause early. Further research is needed to understand the factors driving this increased risk and to develop targeted prevention strategies.

Ongoing Trials and Ethical Considerations

The controversial clinical trial of the hepatitis B vaccine birth dose in Guinea-Bissau remains in a state of flux. The University of Southern Denmark initially set the trial on hold, requesting a review by a WHO research ethics committee. However, Kate O’Brien, head of WHO’s immunization and vaccinations program, stated that the agency had not yet received the request. O’Brien emphasized that the responsibility for ensuring the ethical conduct of research lies with funders and the researchers’ home institutions. The situation highlights the importance of rigorous ethical oversight in clinical trials, particularly when conducted in vulnerable populations.

Looking ahead, the scientific community faces a complex set of challenges. Addressing the funding uncertainties, navigating the evolving landscape of vaccine skepticism, and ensuring equitable access to healthcare will require sustained effort and collaboration. Continued monitoring of emerging data, such as the undercounting of Covid-19 deaths, will be crucial for informing public health strategies and protecting the most vulnerable members of society. The ongoing debate surrounding healthcare fraud and its potential impact on individuals with disabilities underscores the need for careful consideration of the unintended consequences of policy changes.

Test your knowledge with today’s STAT Mini crossword.